£86 million funding announced for new medicine and technology

The government has announced new funding of up to £86 million for UK firms to develop medical breakthroughs.

The package will allow small and medium sized enterprises (SMEs) to develop and test new technologies in the NHS. This could include innovations such as digital technologies to help patients manage their conditions from home instead of a hospital, or to develop new medicines.

Access to this funding will also speed up the time it takes to get new technologies from the lab to patients in the NHS.

The announcement is the first step in taking forward the Accelerated Access Review (AAR) – an independently chaired review, which made recommendations to government on speeding up patient access to new technologies.

Technologies that have previously received support are already bringing benefits to patients. For example, MyCOPD is an online system that helps people with chronic obstructive pulmonary disease (COPD) better manage their condition. It has helped over 32,000 patients by helping them improve their breathing, manage flare-ups and track medicine use. This reduces reliance on GP and hospital appointments.

Health Minister Lord O’Shaughnessy said:

“The government’s ambition is that NHS patients get world-leading, life-changing treatments as fast as possible.

“That can’t happen unless we support medical innovation and tear down the barriers – like speed to market and access to funding – that can get in the way, especially for SMEs.

“Our investment in innovation shows how much we value the UK life sciences sector.”

The funding is split into 4 packages. These include:
•£39 million of funding to the Academic Health Science Networks (ASHNs), enabling them to assess the benefits of new technologies and support NHS uptake of those that deliver real benefits to patients according to the local need
•£35 million Digital Health Technology Catalyst for innovators – this will match-fund the development of digital technologies for use by patients and the NHS
•up to £6 million over the next 3 years to help SMEs with innovative medicines and devices get the evidence they need by testing in the real world, building on existing opportunities such as the Early Access to Medicine Scheme (EAMS)
•£6 million Pathway Transformation Fund, which will help NHS organisations integrate new technologies into everyday practices – this will help overcome more practical obstacles such as training staff on how to use new equipment


To find out more, please click here 

Featured News

New resource for diabetes patients and carers

Digibete is a new online resource to help children and young people, families, communities and healthcare professionals to understand...

Read more

Event: The Future of Healthcare

Date: 19th April 2018, 1600 -1900 Location: Citylabs, Manchester, M13 9NQ The Business Growth Hub are looking for clinicians,...

Read more

Event: Research & Development Conference

Friday 18th May 2018, 9am – 4pm Lancaster Town Hall University Hospitals of Morcambe Bay NHS Foundation Trust have...

Read more

Bionow Business Pitching Event

Date: Wednesday 21st March 2018 Venue: Liverpool Bio-Innovation Hub Bionow and the Liverpool Bio-Innovation Hub (LIBH) are co-hosting a...

Read more

Test Beds wave 2 launch

Following the announcement by NHS England’s Chief Executive Simon Stevens at Expo last September, the second wave of the...

Read more

Opportunity – STEP INto Healthcare and Masterclass Series

TRUSTECH, in partnership with the Business Growth Hub and Health Innovation Manchester, are delivering fully funded support to B2B...

Read more

Life science businesses invited to STEP INto Healthcare

Life science companies based in the Greater Manchester (GM) area are invited to take part in Health Innovation Manchester’s...

Read more

Asthma-related research grants

Asthma UK and Innovate UK have announced grants of between £50,000 and £250,000 are available to develop tools for...

Read more

Subscribe for Updates

Register to receive newsletters and information about new programmes and events.